The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities
Current Oncology · 01.07.2024 · 31 (7) · 3826-3844
DOI: 10.3390/curroncol31070283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 01.07.2024. Verfasst von Bianca Garlisi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada. Hauptthemen laut MEDLINE: Tumor Microenvironment, Ovarian Neoplasms. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Canadian Institutes of Health Research, Ovarian Cancer Canada, the Cancer Research Society.
Abstract (Originalsprache)
The tumor microenvironment (TME) in ovarian cancer (OC) has much greater complexity than previously understood. In response to aggressive pro-angiogenic stimulus, blood vessels form rapidly and are dysfunctional, resulting in poor perfusion, tissue hypoxia, and leakiness, which leads to increased interstitial fluid pressure (IFP). Decreased perfusion and high IFP significantly inhibit the uptake of therapies into the tumor. Within the TME, there are numerous inhibitor cells, such as myeloid-derived suppressor cells (MDSCs), tumor association macrophages (TAMs), regulatory T cells (Tregs), and cancer-associated fibroblasts (CAFs) that secrete high numbers of immunosuppressive cytokines. This immunosuppressive environment is thought to contribute to the lack of success of immunotherapies such as immune checkpoint inhibitor (ICI) treatment. This review discusses the components of the TME in OC, how these characteristics impede therapeutic efficacy, and some strategies to alleviate this inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada.
ORCID-Profile: Leslie M Ogilvie, Jim Petrik
Förderung
- the Canadian Institutes of Health Research
- Ovarian Cancer Canada
- the Cancer Research Society
Zitieren
APA
Garlisi, B., Lauks, S., Aitken, C., Ogilvie, L. M., Lockington, C., Petrik, D., Eichhorn, J. S., & Petrik, J. (2024). The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities. Current Oncology, 31(7), 3826-3844. https://doi.org/10.3390/curroncol31070283
Vancouver
Garlisi B, Lauks S, Aitken C, Ogilvie LM, Lockington C, Petrik D, et al. The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities. Current Oncology. 2024;31(7):3826-3844. doi:10.3390/curroncol31070283
BibTeX
@article{Garlisi2024,
author = {Garlisi, Bianca and Lauks, Sylvia and Aitken, Caroline and Ogilvie, Leslie M and Lockington, Cielle and Petrik, Duncan and Eichhorn, Jan Soeren and Petrik, Jim},
title = {The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities},
journal = {Current Oncology},
year = {2024},
volume = {31},
number = {7},
pages = {3826--3844},
doi = {10.3390/curroncol31070283}
}
EUVIMED